Ongoing measles transmission in 2026 has already produced 2,566 confirmed U.S. cases as of mid-August, surpassing the full-year 2025 total of 2,289 and marking the highest annual count since 1991, according to CDC data tracked by the American Academy of Pediatrics. This surge stems primarily from 38 new outbreaks, with 94% of cases outbreak-associated and 93% occurring in unvaccinated or unknown-status individuals amid national MMR kindergarten coverage falling to 92.4%. Most infections affect school-age children, with a 7% hospitalization rate and zero deaths reported so far. The Pan American Health Organization is scheduled to review elimination status—granted in 2000—later this year, while CDC weekly updates and state surveillance will continue to shape totals through year-end.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertMasernfälle in den USA im Jahr 2026?
Masernfälle in den USA im Jahr 2026?
$7,844,453 Vol.
$7,844,453 Vol.
30. Dez. 2026
↑4,5k
57%
↑3k
97%
↑3,5 Tsd.
93%
↑4k
81%
↑5k
38%
↑7,5k
12%
↑10k
6%
↑12,5k
6%
$7,844,453 Vol.
$7,844,453 Vol.
30. Dez. 2026
↑4,5k
$28 Vol.
57%
↑3k
$90,886 Vol.
97%
↑3,5 Tsd.
$14,030 Vol.
93%
↑4k
$229,105 Vol.
81%
↑5k
$231,837 Vol.
38%
↑7,5k
$185,371 Vol.
12%
↑10k
$6,516,697 Vol.
6%
↑12,5k
$350,733 Vol.
6%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in 2026 has already produced 2,566 confirmed U.S. cases as of mid-August, surpassing the full-year 2025 total of 2,289 and marking the highest annual count since 1991, according to CDC data tracked by the American Academy of Pediatrics. This surge stems primarily from 38 new outbreaks, with 94% of cases outbreak-associated and 93% occurring in unvaccinated or unknown-status individuals amid national MMR kindergarten coverage falling to 92.4%. Most infections affect school-age children, with a 7% hospitalization rate and zero deaths reported so far. The Pan American Health Organization is scheduled to review elimination status—granted in 2000—later this year, while CDC weekly updates and state surveillance will continue to shape totals through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Markt eröffnet: Feb 16, 2026, 11:51 AM ET
Volumen
$7,844,453Enddatum
31. Dez. 2026Markt eröffnet
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in 2026 has already produced 2,566 confirmed U.S. cases as of mid-August, surpassing the full-year 2025 total of 2,289 and marking the highest annual count since 1991, according to CDC data tracked by the American Academy of Pediatrics. This surge stems primarily from 38 new outbreaks, with 94% of cases outbreak-associated and 93% occurring in unvaccinated or unknown-status individuals amid national MMR kindergarten coverage falling to 92.4%. Most infections affect school-age children, with a 7% hospitalization rate and zero deaths reported so far. The Pan American Health Organization is scheduled to review elimination status—granted in 2000—later this year, while CDC weekly updates and state surveillance will continue to shape totals through year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$7,844,453Enddatum
31. Dez. 2026Markt eröffnet
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...Ongoing measles transmission in 2026 has already produced 2,566 confirmed U.S. cases as of mid-August, surpassing the full-year 2025 total of 2,289 and marking the highest annual count since 1991, according to CDC data tracked by the American Academy of Pediatrics. This surge stems primarily from 38 new outbreaks, with 94% of cases outbreak-associated and 93% occurring in unvaccinated or unknown-status individuals amid national MMR kindergarten coverage falling to 92.4%. Most infections affect school-age children, with a 7% hospitalization rate and zero deaths reported so far. The Pan American Health Organization is scheduled to review elimination status—granted in 2000—later this year, while CDC weekly updates and state surveillance will continue to shape totals through year-end.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen